Patent

Pegylated bioactive peptides and uses thereof (US Patent 10918730)

GRIFFON PHARMACEUTICALS INTERNATIONAL SA · Granted Feb 16, 2021 · Filed Apr 18, 2017

Patent number: 10918730 Kind code: B2 Granted: 2021-02-16 Filed: 2017-04-18 Inventors: Krishna G. Peri (Montreal, CA) Assignees: GRIFFON PHARMACEUTICALS INTERNATIONAL SA (Epalinges, CH) CPC: C07K 14/60

Abstract

Described herein are bioactive peptides that are modified at one or more positions with a PEG moiety. An example of such a PEGylated bioactive peptide is a GHRH analog that is modified at one or more positions with a PEG moiety. Also described are pharmaceutically acceptable salts thereof and pharmaceutical

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API